Mirador Capital Partners’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.29M | Buy |
|
|||||
|
2025
Q2 | $3.23M | Buy |
|
|||||
|
2025
Q1 | $2.32M | Buy |
|
|||||
|
2024
Q4 | $3.02M | Buy |
|
|||||
|
2024
Q3 | $3.95M | Buy |
|
|||||
|
2024
Q2 | $4.16M | Buy |
|
|||||
|
2024
Q1 | $4.4M | Sell |
|
|||||
|
2023
Q4 | $4.28M | Buy |
|
|||||
|
2023
Q3 | $2.97M | Buy |
|
|||||
|
2023
Q2 | $3.55M | Buy |
|
|||||
|
2023
Q1 | $3.63M | Sell |
|
|||||
|
2022
Q4 | $4.7M | Sell |
|
|||||
|
2022
Q3 | $3.01M | Buy |
|
|||||
|
2022
Q2 | $2.87M | Buy |
|
|||||
|
2022
Q1 | $3.07M | Buy |
|
|||||
|
2021
Q4 | $3.33M | Buy |
|
|||||
|
2021
Q3 | $3.98M | Sell |
|
|||||
|
2021
Q2 | $2.63M | Buy |
|
|||||
|
2021
Q1 | $1.56M | Buy |
|
|||||
|
2020
Q4 | $469K | Buy |
|
|||||
|
2020
Q3 | $378K | Buy |
|
|||||
|
2020
Q2 | $249K | Buy |
|
|||||
|
2020
Q1 | $27K | Buy |
|